Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Squamous Cell Skin Cancer
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Skin Cancer (1090
)
Bowens Disease (2
)
Skin Cancer (1090
)
Bowens Disease (2
)
›
Associations
(22)
News
Trials
Search handles
@jamecancerdoc
@rbryanbell
Search handles
@jamecancerdoc
@rbryanbell
Filter by
Latest
9ms
Please help. How do you handle difficult to treat and locally invasive squamous cell carcinoma of the skin in a patient with long standing well-controlled AIH and well compensated cirrhosis on azathioprine. #livertwitter @AutoImmuneLiver @DrCynthiaLevy (@serperm)
9 months ago
Clinical
9ms
WATCH: A panel of skin cancer experts have a comprehensive discussion on advanced cutaneous squamous cell carcinoma and melanoma, and offer insights on the evolving treatment landscape. @MunTheLoon #oncology #medtwitter https://t.co/J8uv9aTiFC (@OncLive)
9 months ago
Metastases
10ms
New prediction model with good discrimination+calibration to predict metastasis in cutaneous squamous cell carcinoma presented by Marlies Wakkee in a UK and Netherlands collaboration Great to see rigorous methods in dermatology prediction research #WCD2023Singapore #WCD2023 (@ZZNYiu)
10 months ago
10ms
Brilliant lecture by @DrNeilGross on neoadjuvant immunotherapy and response-adapted oncologic surgery for patients with cutaneous squamous cell carcinoma, waiting for the results of Phase 3 NRG-HN2316 Trial #cSCC #skincancer #IFHNOS23 @Ifhnos_official (@elenacolomboMD)
10 months ago
Clinical • P3 data • Surgery
10ms
What an intense and valuable symposium on cutaneous SCC by @amzhncs at #IFHNOS23 in Rome (@drbruceashford)
10 months ago
10ms
Excellent panel discussion on challenges in cutaneous squamous cell carcinoma - exciting data to consider for immunosuppressed and neoadjuvant settings… hosted by Dirk Schadendorf (remotely) with @MandalaMario @CelesteLebbe @Regeneron @sanofi @uclh #postchicagoskin2023 (@DrHMShaw)
10 months ago
Clinical
10ms
Standing room only for Rahul Ladwa’s talk on the role of medical oncology in advanced cutaneous SCC #IFHNOS23 Are we seeing the end of surgery?? (@drbruceashford)
10 months ago
Surgery • Metastases
10ms
Consider non melanoma skin cancer (NMSC) ? high risk cutaneous squamous cell carcinoma cSCC https://t.co/p4Zh1HQaYn (@kym83810679)
10 months ago
10ms
Brilliant lecture from @DrNeilGross at #ICOMS2023 highlighting his pivotal work on neoadjuvant immunotherapy for the treatment of locally advanced cutaneous squamous cell carcinoma. Exciting Ph3 trial coming up to compare neoadjuvant IO to SOC surgery + RT. @MDAndersonNews (@rbryanbell)
10 months ago
Clinical • Surgery • Metastases
11ms
Thank you to @AndrewBrohl for stopping by to discuss results from a phase 1b trial of the novel personalized cancer vaccine IFx-Hu2.0 in ICI- resistant Merkel cell carcinoma and cutaneous squamous cell carcinoma! @ASCO #ASCO23 #ASCO2023 #oncology (@OncLive)
11 months ago
Clinical • P1 data
|
IFx-2.0
11ms
Moffitt's Dr. @AndrewBrohl discusses a phase 1b trial of IFx-Hu2.0, a novel personalized cancer vaccine, in checkpoint inhibitor resistant Merkel cell carcinoma and cutaneous squamous cell carcinoma while at #ASCO23. Learn more ➡️ https://t.co/bCfSUUHEIf #MoffittASCO23 @ASCO (@MoffittNews)
11 months ago
Clinical • Checkpoint inhibition
|
IFx-2.0
11ms
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial https://t.co/bLgTFZw5ga by Dr. Renata Ferrarotto, @ANaingMD et al (@LabNaing)
11 months ago
Clinical
|
Keytruda (pembrolizumab)
11ms
Immunotherapy a Game Changer for Case of Advanced Cutaneous Squamous Cell Carcinoma – Consult QD https://t.co/9ZHx0x4cQD (@jamecancerdoc)
11 months ago
Clinical • Metastases
12ms
Important study from @UCSFMedicine: High prevalence of HSIL and anal SCC in MSM #IBD patients but 🟰 non-IBD controls. Implies that the risk is driven largely by other risk factors and not IS meds. Could extrapolate this to non-skin SCC in both sexes? #DrJustinFields #DDW2023 (@mchiorean4)
12 months ago
Clinical
12ms
This week Dr James Pham presents his research on egfr (epidermal growth factor receptor) inhibitors and their role in cutaneous squamous cell carcinoma at the European Association of Dermatology Oncology Congress in Italy! Great job James! #eado @AnthonyMJoshua @JiaJennyLiu (@kinghorncancer)
12 months ago
EGFR (Epidermal growth factor receptor)
1year
Squamoid cells Any skin lesion? Skin SCC can show GATA3 positivity (@Garima3103)
1 year ago
GATA3 (GATA binding protein 3)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login